MedTrace Logo

Effects of HX106 on Improvement in Cognitive-Bio-Markers of Memory Function

NCT01956097 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2025-08-22

Study results available
· View outcomes & findings →

Summary

The objectives of the current study are to evaluate the efficacy and safety of HX106 in healthy adults with subjective memory complaints for improving cognitive and neurobiolgoical markers of memory.

Conditions

  • Healthy Adults With Subjective Memory Complaints

Interventions

DIETARY_SUPPLEMENT

HX106 590mg

DIETARY_SUPPLEMENT

HX106 1180mg

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • Ewha Womans University

    lead OTHER

Principal Investigators

  • In Kyoon Lyoo, MD, PhD, MMS · Ewha W. University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01956097 on ClinicalTrials.gov